Simvastatin & Blood Donation: Eligibility Checklist
Simvastatin (HMG-CoA reductase inhibitor) is not a deferral criterion for blood donation per FDA/AABB. However, donors must meet general wellness standards.
Key Considerations
- Stable dose ≥4 weeks (some centers prefer 8 weeks).
- Normal LFTs – if recent labs show AST/ALT >2× ULN, defer until normalized.
- No myopathy symptoms (unexplained muscle pain, CK elevation).
- Underlying indication controlled (ASCVD, diabetes, familial hypercholesterolemia).
Action
- Bring medication list to donation.
- Disclose statin use during health history.
- If deferred, ask for specific reason and re-evaluation timeline.
Most statin users donate without issue.
Blood Disorders - Related Articles
- Understanding and Treating Purpura: A Guide to Thrombocytopenia
- Why Donate Blood? Life-Saving Impact, Health Benefits, and Community Value
- Low Blood Oxygen (Hypoxemia): Causes, Mechanisms & Risk Factors
- Understanding Low RDW-CV: Causes and Clinical Significance
- Thrombocytopenia: Symptoms, Causes & What to Do
- What Blood Carries: Essential Substances and Their Vital Functions
- Hyperkalemia: Causes, Symptoms & Treatment - A Comprehensive Guide
